Ebene News – GB – Serum Institute request for the use of an emergency vaccine to be considered today

The Serum Institute of India’s application for emergency use approval of the coronavirus vaccine developed by the University of Oxford and pharmaceutical company AstraZeneca will be reviewed by an expert today , sources told NDTV, hours after the UK gave the same clearance

The head of the Serum Institute, Adar Poonawalla, welcomed the decision “This is great news and encouraging We will await final approval from Indian regulators,” he told NDTV

Last month, the Serum Institute, which makes the vaccine that has been named “Covishield,” said a positive test result in a late state would allow it to seek approval by the end of year for emergency use of its candidate, before getting approval for full introduction by February or March

The world’s largest vaccine maker has already produced around 50 million doses of the Oxford-AstraZeneca vaccine and plans to increase it to 100 million by March of next year, Mr. Poonawalla

Besides SII, Bharat Biotech and Pfizer had applied to the Comptroller General of Medicines of India (DCGI) for emergency use authorization for their COVID-19 vaccines this month

The UK on Wednesday approved the University of Oxford-AstraZeneca vaccine for human use, the second coronavirus vaccine to be cleared for deployment in Britain after Pfizer-BioNTech jabs

The Oxford vaccine was under evaluation by the UK regulator – the Medicines and Health Products Regulatory Agency (MHRA) – after the government submitted final data last week

MHRA approval means the vaccine is both “safe and effective” and the UK Department of Health and Social Affairs (DHSC) has said the National Health Service (NHS) will prioritize administration of the first of two doses vaccine to those in the highest risk groups quickly

Like Pfizer-BioNTech jabs, Covishield is similar in requiring two doses but it is easier to administer as it does not need extremely low temperatures for storage It is also inexpensive and easy to mass produce

“);
return to focus ();
api = “https: // genndtvcom / screenshot / Webaspx screenshot? apikey = 3cb0166badabscreenshot7bfa6b56b4c82c40b620&siteid = 7&width = 600&height = 600&scale = 1&scale = 1&scale =” 1CSSARCHARscale = ”
$ ajax ({
url: api,
dataType: “jsonp”,
jsonp: “callback”,
timeout: 10,
asynchronous:! 1,
success: function (e) {
var n = “”;
loc = window location;
loc = lochref;
loc = locreplace (“#”, “”);
snapid = esnapchatid;
renderfirebaseinitializeApp ({projectId: “firestore-realtime-push”});
renderfirebasefirestore () collection (“snapchatndtvcom”) doc (snapid) onSnapshot (
function {
var t = eData ();
imgpath = timagepath;
if (imgpath! = ”) {n = loc ‘? sticker = ‘image tchemin; renderlocationhref = “https: // wwwSnapchatcom / scan? attachmentUrl =” n;}

})

},
error: function () {
renderlocationhref = “https: // wwwSnapchatcom / scan? attachmentUrl =” n;

}

})

}

Follow the latest news live on NDTVcom Follow our special coverage of the coronavirus pandemic in India and receive news from around the world

Indian Serum Institute, Vaccine, India, Adar Poonawalla, Pneumococcal vaccine, AstraZeneca, Coronavirus

Ebene News – GB – Serum Institute request for vaccine use urgently to consider today

Source: https://www.ndtv.com/india-news/serum-institutes-application-for-emergency-use-approval-of-covid-vaccine-to-be-considered-by-expert-panel-today-2345526